Determining if Tinea Corporis is Extensive
Tinea corporis is considered extensive when lesions cannot be adequately covered or when multiple widespread lesions are present that would require systemic rather than topical therapy alone. 1
Practical Classification Criteria
The determination of "extensive" tinea corporis is based on two key operational definitions from sports medicine guidelines:
Extensive Disease Indicators:
- Multiple lesions that cannot be covered with standard dressings 1
- Widespread distribution across multiple body areas 2, 3
- Active lesions confirmed by KOH preparation showing hyphae/arthroconidia or positive culture 1
- Deep or severe infection that has failed topical treatment 2, 3
Localized Disease Indicators:
- Solitary or closely clustered lesions that can be covered with gas-permeable dressing 1
- Limited to one anatomical area 2
- Responsive to topical therapy 4, 5
Clinical Decision Algorithm
Step 1: Count and Map Lesions
- Single or few closely grouped lesions = localized 1
- Multiple scattered lesions across different body regions = extensive 2, 3
Step 2: Assess Coverability
- Can all lesions be covered with standard dressings? If yes = localized 1
- If lesions are too numerous or widespread to cover = extensive 1
Step 3: Evaluate Treatment Response
- If topical therapy alone would be adequate = localized 4, 5
- If systemic therapy is required = extensive 2, 3
Treatment Implications
The distinction between localized and extensive disease directly determines management:
Localized tinea corporis:
- Topical antifungals (terbinafine, naftifine, or azoles) for 2 weeks 4, 5
- Minimum 72 hours of treatment before return to contact activities 1
- Lesions must be covered with gas-permeable dressing 1
Extensive tinea corporis:
- Systemic antifungal therapy is indicated 2, 3
- Itraconazole 100 mg daily for 15 days (87% mycological cure rate) 6, 7
- Terbinafine is superior for Trichophyton tonsurans infections 6, 7
- Disqualification from contact sports until adequately treated 1
Common Pitfalls to Avoid
- Do not rely solely on clinical appearance - confirm with KOH preparation or culture, especially in extensive cases 1, 2
- Do not stop treatment based only on clinical improvement - mycological cure (negative microscopy and culture) is the definitive endpoint 6, 7
- Do not underestimate immunocompromised patients - they require systemic therapy even for seemingly limited disease 7, 2
- Do not confuse inflammatory presentations with bacterial infection - consider secondary infection but recognize that inflammation may be part of the host response 1
Confirmation of Extent
Laboratory confirmation is essential for extensive disease: